Results 31 to 40 of about 3,502 (121)

Safety evaluation of the food enzyme bacillolysin from the genetically modified Bacillus amyloliquefaciens strain NPR

open access: yesEFSA Journal, Volume 23, Issue 2, February 2025.
Abstract The food enzyme bacillolysin (EC 3.4.24.28) is produced with the genetically modified Bacillus amyloliquefaciens strain NPR by DSM Food Specialties B.V. The production strain meets the requirements for the qualified presumption of safety (QPS) status. The genetic modifications do not give rise to safety concerns. The food enzyme was considered
EFSA Panel on Food Enzymes (FEZ)   +19 more
wiley   +1 more source

Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 1, January 2025.
Novel Ubiquitin‐Specific Protease‐30 (USP30) inhibitors target a key deubiquitinating enzyme, USP30, promoting the ubiquitination and subsequent clearance of dysfunctional mitochondria through the mitophagy pathway. This process offers therapeutic benefits in neurodegenerative diseases by enhancing neuronal cell health.
Ankit Siwach   +3 more
wiley   +1 more source

Current Understanding of Feather Keratin and Keratinase and Their Applications in Biotechnology

open access: yesBiochemistry Research International, Volume 2025, Issue 1, 2025.
The food industry generates substantial keratin waste, particularly chicken feathers, which are rich in amino acids and essential nutrients. However, the insolubility of keratin presents a significant challenge to its conversion. Keratinase, an enzyme produced by certain fungi and bacteria, offers a promising solution by degrading feather keratin into ...
Thanakorn Moktip   +6 more
wiley   +1 more source

Charcot‐Marie‐Tooth disease in children

open access: yesAnnals of the Child Neurology Society, Volume 2, Issue 4, Page 256-268, December 2024.
Abstract Charcot‐Marie‐Tooth (CMT) disease represents a diverse group of inherited neuropathies with a broad spectrum of symptoms. It is the most prevalent inherited neuropathy, with an estimated prevalence ranging from 9.7 to 82 cases per 100,000 individuals.
Ezgi Saylam   +4 more
wiley   +1 more source

Butyrate Metabolism‐Related Gene Signature in Tumor Immune Microenvironment in Lung Adenocarcinoma: A Comprehensive Bioinformatics Study

open access: yesImmunity, Inflammation and Disease, Volume 12, Issue 12, December 2024.
We established a novel gene signature associated with butyrate metabolism, serving as a sensitive predictive biomarker for the prognosis of LUAD patients. We underscored the necessity for further comprehensive investigations to unveil the regulatory mechanisms governing butyrate metabolism in LUAD. ABSTRACT Background Experimental results have verified
Jing Zhao   +6 more
wiley   +1 more source

The proteomic landscape of extracellular vesicles derived from human intervertebral disc cells

open access: yesJOR SPINE, Volume 7, Issue 4, December 2024.
Extracellular vesicles (EVs) derived from human intervertebral disc cells present markers CD9, CD81, CD82, ALIX, FLOT1/2, TSG101, and ANXA5 with differential expression levels linked to the degenerative grade of the tissue. The proteomic cargo is majorly shared but the expression levels vary with degeneration grade.
Li Li   +8 more
wiley   +1 more source

Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cells [PDF]

open access: gold, 2020
Chieh-Yang Cheng   +6 more
openalex   +1 more source

N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface [PDF]

open access: green, 2000
Véronique HOSPITAL   +6 more
openalex   +1 more source

The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF) [PDF]

open access: green, 2002
Véronique HOSPITAL   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy